Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Gastrointestinal Market Growth (Status and Outlook) 2022-2028

  • LP 4704809
  • 102 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Gastrointestinal will have significant change from previous year. According to our (LP Information) latest study, the global Gastrointestinal market size is USD million in 2022 from USD 33960 million in 2021, with a change of % between 2021 and 2022. The global Gastrointestinal market size will reach USD 42980 million in 2028, growing at a CAGR of 3.4% over the analysis period.

The United States Gastrointestinal market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gastrointestinal market, reaching US$ million by the year 2028. As for the Europe Gastrointestinal landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Gastrointestinal players cover AstraZenec, Sanofi, Bayer, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Prescription Gastrointestinal Drug

OTC Gastrointestinal Drug

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Chronic Gastritis

Functional Dyspepsia

Peptic Ulcer

Acute Gastroenteritis

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

AstraZenec

Sanofi

Bayer

Pfizer

GlaxoSmithKline

Teva

Zeria(Tillotts)

Perrigo

Boehringer Ingelheim

Purdue Pharma

C.B. Fleet

Abbott

Jiangzhong

Xian-Janssen

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gastrointestinal Market Size 2017-2028

2.1.2 Gastrointestinal Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Gastrointestinal Segment by Type

2.2.1 Prescription Gastrointestinal Drug

2.2.2 OTC Gastrointestinal Drug

2.3 Gastrointestinal Market Size by Type

2.3.1 Gastrointestinal Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Gastrointestinal Market Size Market Share by Type (2017-2022)

2.4 Gastrointestinal Segment by Application

2.4.1 Chronic Gastritis

2.4.2 Functional Dyspepsia

2.4.3 Peptic Ulcer

2.4.4 Acute Gastroenteritis

2.4.5 Others

2.5 Gastrointestinal Market Size by Application

2.5.1 Gastrointestinal Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Gastrointestinal Market Size Market Share by Application (2017-2022)

3 Gastrointestinal Market Size by Player

3.1 Gastrointestinal Market Size Market Share by Players

3.1.1 Global Gastrointestinal Revenue by Players (2020-2022)

3.1.2 Global Gastrointestinal Revenue Market Share by Players (2020-2022)

3.2 Global Gastrointestinal Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Gastrointestinal by Regions

4.1 Gastrointestinal Market Size by Regions (2017-2022)

4.2 Americas Gastrointestinal Market Size Growth (2017-2022)

4.3 APAC Gastrointestinal Market Size Growth (2017-2022)

4.4 Europe Gastrointestinal Market Size Growth (2017-2022)

4.5 Middle East & Africa Gastrointestinal Market Size Growth (2017-2022)

5 Americas

5.1 Americas Gastrointestinal Market Size by Country (2017-2022)

5.2 Americas Gastrointestinal Market Size by Type (2017-2022)

5.3 Americas Gastrointestinal Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gastrointestinal Market Size by Region (2017-2022)

6.2 APAC Gastrointestinal Market Size by Type (2017-2022)

6.3 APAC Gastrointestinal Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Gastrointestinal by Country (2017-2022)

7.2 Europe Gastrointestinal Market Size by Type (2017-2022)

7.3 Europe Gastrointestinal Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gastrointestinal by Region (2017-2022)

8.2 Middle East & Africa Gastrointestinal Market Size by Type (2017-2022)

8.3 Middle East & Africa Gastrointestinal Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Gastrointestinal Market Forecast

10.1 Global Gastrointestinal Forecast by Regions (2023-2028)

10.1.1 Global Gastrointestinal Forecast by Regions (2023-2028)

10.1.2 Americas Gastrointestinal Forecast

10.1.3 APAC Gastrointestinal Forecast

10.1.4 Europe Gastrointestinal Forecast

10.1.5 Middle East & Africa Gastrointestinal Forecast

10.2 Americas Gastrointestinal Forecast by Country (2023-2028)

10.2.1 United States Gastrointestinal Market Forecast

10.2.2 Canada Gastrointestinal Market Forecast

10.2.3 Mexico Gastrointestinal Market Forecast

10.2.4 Brazil Gastrointestinal Market Forecast

10.3 APAC Gastrointestinal Forecast by Region (2023-2028)

10.3.1 China Gastrointestinal Market Forecast

10.3.2 Japan Gastrointestinal Market Forecast

10.3.3 Korea Gastrointestinal Market Forecast

10.3.4 Southeast Asia Gastrointestinal Market Forecast

10.3.5 India Gastrointestinal Market Forecast

10.3.6 Australia Gastrointestinal Market Forecast

10.4 Europe Gastrointestinal Forecast by Country (2023-2028)

10.4.1 Germany Gastrointestinal Market Forecast

10.4.2 France Gastrointestinal Market Forecast

10.4.3 UK Gastrointestinal Market Forecast

10.4.4 Italy Gastrointestinal Market Forecast

10.4.5 Russia Gastrointestinal Market Forecast

10.5 Middle East & Africa Gastrointestinal Forecast by Region (2023-2028)

10.5.1 Egypt Gastrointestinal Market Forecast

10.5.2 South Africa Gastrointestinal Market Forecast

10.5.3 Israel Gastrointestinal Market Forecast

10.5.4 Turkey Gastrointestinal Market Forecast

10.5.5 GCC Countries Gastrointestinal Market Forecast

10.6 Global Gastrointestinal Forecast by Type (2023-2028)

10.7 Global Gastrointestinal Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 AstraZenec

11.1.1 AstraZenec Company Information

11.1.2 AstraZenec Gastrointestinal Product Offered

11.1.3 AstraZenec Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 AstraZenec Main Business Overview

11.1.5 AstraZenec Latest Developments

11.2 Sanofi

11.2.1 Sanofi Company Information

11.2.2 Sanofi Gastrointestinal Product Offered

11.2.3 Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sanofi Main Business Overview

11.2.5 Sanofi Latest Developments

11.3 Bayer

11.3.1 Bayer Company Information

11.3.2 Bayer Gastrointestinal Product Offered

11.3.3 Bayer Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Bayer Main Business Overview

11.3.5 Bayer Latest Developments

11.4 Pfizer

11.4.1 Pfizer Company Information

11.4.2 Pfizer Gastrointestinal Product Offered

11.4.3 Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Pfizer Main Business Overview

11.4.5 Pfizer Latest Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Information

11.5.2 GlaxoSmithKline Gastrointestinal Product Offered

11.5.3 GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 GlaxoSmithKline Main Business Overview

11.5.5 GlaxoSmithKline Latest Developments

11.6 Teva

11.6.1 Teva Company Information

11.6.2 Teva Gastrointestinal Product Offered

11.6.3 Teva Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Teva Main Business Overview

11.6.5 Teva Latest Developments

11.7 Zeria(Tillotts)

11.7.1 Zeria(Tillotts) Company Information

11.7.2 Zeria(Tillotts) Gastrointestinal Product Offered

11.7.3 Zeria(Tillotts) Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Zeria(Tillotts) Main Business Overview

11.7.5 Zeria(Tillotts) Latest Developments

11.8 Perrigo

11.8.1 Perrigo Company Information

11.8.2 Perrigo Gastrointestinal Product Offered

11.8.3 Perrigo Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Perrigo Main Business Overview

11.8.5 Perrigo Latest Developments

11.9 Boehringer Ingelheim

11.9.1 Boehringer Ingelheim Company Information

11.9.2 Boehringer Ingelheim Gastrointestinal Product Offered

11.9.3 Boehringer Ingelheim Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Boehringer Ingelheim Main Business Overview

11.9.5 Boehringer Ingelheim Latest Developments

11.10 Purdue Pharma

11.10.1 Purdue Pharma Company Information

11.10.2 Purdue Pharma Gastrointestinal Product Offered

11.10.3 Purdue Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Purdue Pharma Main Business Overview

11.10.5 Purdue Pharma Latest Developments

11. C.B. Fleet

11.11.1 C.B. Fleet Company Information

11.11.2 C.B. Fleet Gastrointestinal Product Offered

11.11.3 C.B. Fleet Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 C.B. Fleet Main Business Overview

11.11.5 C.B. Fleet Latest Developments

11.12 Abbott

11.12.1 Abbott Company Information

11.12.2 Abbott Gastrointestinal Product Offered

11.12.3 Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Abbott Main Business Overview

11.12.5 Abbott Latest Developments

11.13 Jiangzhong

11.13.1 Jiangzhong Company Information

11.13.2 Jiangzhong Gastrointestinal Product Offered

11.13.3 Jiangzhong Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Jiangzhong Main Business Overview

11.13.5 Jiangzhong Latest Developments

11.14 Xian-Janssen

11.14.1 Xian-Janssen Company Information

11.14.2 Xian-Janssen Gastrointestinal Product Offered

11.14.3 Xian-Janssen Gastrointestinal Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Xian-Janssen Main Business Overview

11.14.5 Xian-Janssen Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Gastrointestinal Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Prescription Gastrointestinal Drug

Table 3. Major Players of OTC Gastrointestinal Drug

Table 4. Gastrointestinal Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Gastrointestinal Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Gastrointestinal Market Size Market Share by Type (2017-2022)

Table 7. Gastrointestinal Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Gastrointestinal Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Gastrointestinal Market Size Market Share by Application (2017-2022)

Table 10. Global Gastrointestinal Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Gastrointestinal Revenue Market Share by Player (2020-2022)

Table 12. Gastrointestinal Key Players Head office and Products Offered

Table 13. Gastrointestinal Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Gastrointestinal Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Gastrointestinal Market Size Market Share by Regions (2017-2022)

Table 18. Americas Gastrointestinal Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Gastrointestinal Market Size Market Share by Country (2017-2022)

Table 20. Americas Gastrointestinal Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Gastrointestinal Market Size Market Share by Type (2017-2022)

Table 22. Americas Gastrointestinal Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Gastrointestinal Market Size Market Share by Application (2017-2022)

Table 24. APAC Gastrointestinal Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Gastrointestinal Market Size Market Share by Region (2017-2022)

Table 26. APAC Gastrointestinal Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Gastrointestinal Market Size Market Share by Type (2017-2022)

Table 28. APAC Gastrointestinal Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Gastrointestinal Market Size Market Share by Application (2017-2022)

Table 30. Europe Gastrointestinal Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Gastrointestinal Market Size Market Share by Country (2017-2022)

Table 32. Europe Gastrointestinal Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Gastrointestinal Market Size Market Share by Type (2017-2022)

Table 34. Europe Gastrointestinal Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Gastrointestinal Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Gastrointestinal Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Gastrointestinal Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Gastrointestinal Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Gastrointestinal Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Gastrointestinal Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Gastrointestinal Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Gastrointestinal

Table 43. Key Market Challenges & Risks of Gastrointestinal

Table 44. Key Industry Trends of Gastrointestinal

Table 45. Global Gastrointestinal Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Gastrointestinal Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Gastrointestinal Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Gastrointestinal Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Gastrointestinal Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Gastrointestinal Market Size Market Share Forecast by Application (2023-2028)

Table 51. AstraZenec Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 52. AstraZenec Gastrointestinal Product Offered

Table 53. AstraZenec Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. AstraZenec Main Business

Table 55. AstraZenec Latest Developments

Table 56. Sanofi Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 57. Sanofi Gastrointestinal Product Offered

Table 58. Sanofi Main Business

Table 59. Sanofi Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Sanofi Latest Developments

Table 61. Bayer Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 62. Bayer Gastrointestinal Product Offered

Table 63. Bayer Main Business

Table 64. Bayer Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Bayer Latest Developments

Table 66. Pfizer Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 67. Pfizer Gastrointestinal Product Offered

Table 68. Pfizer Main Business

Table 69. Pfizer Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Pfizer Latest Developments

Table 71. GlaxoSmithKline Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 72. GlaxoSmithKline Gastrointestinal Product Offered

Table 73. GlaxoSmithKline Main Business

Table 74. GlaxoSmithKline Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. GlaxoSmithKline Latest Developments

Table 76. Teva Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 77. Teva Gastrointestinal Product Offered

Table 78. Teva Main Business

Table 79. Teva Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Teva Latest Developments

Table 81. Zeria(Tillotts) Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 82. Zeria(Tillotts) Gastrointestinal Product Offered

Table 83. Zeria(Tillotts) Main Business

Table 84. Zeria(Tillotts) Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Zeria(Tillotts) Latest Developments

Table 86. Perrigo Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 87. Perrigo Gastrointestinal Product Offered

Table 88. Perrigo Main Business

Table 89. Perrigo Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Perrigo Latest Developments

Table 91. Boehringer Ingelheim Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 92. Boehringer Ingelheim Gastrointestinal Product Offered

Table 93. Boehringer Ingelheim Main Business

Table 94. Boehringer Ingelheim Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Boehringer Ingelheim Latest Developments

Table 96. Purdue Pharma Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 97. Purdue Pharma Gastrointestinal Product Offered

Table 98. Purdue Pharma Main Business

Table 99. Purdue Pharma Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Purdue Pharma Latest Developments

Table 101. C.B. Fleet Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 102. C.B. Fleet Gastrointestinal Product Offered

Table 103. C.B. Fleet Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. C.B. Fleet Main Business

Table 105. C.B. Fleet Latest Developments

Table 106. Abbott Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 107. Abbott Gastrointestinal Product Offered

Table 108. Abbott Main Business

Table 109. Abbott Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Abbott Latest Developments

Table 111. Jiangzhong Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 112. Jiangzhong Gastrointestinal Product Offered

Table 113. Jiangzhong Main Business

Table 114. Jiangzhong Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Jiangzhong Latest Developments

Table 116. Xian-Janssen Details, Company Type, Gastrointestinal Area Served and Its Competitors

Table 117. Xian-Janssen Gastrointestinal Product Offered

Table 118. Xian-Janssen Main Business

Table 119. Xian-Janssen Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Xian-Janssen Latest Developments

List of Figures

Figure 1. Gastrointestinal Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Gastrointestinal Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Gastrointestinal Market Size Market Share by Type in 2021

Figure 7. Gastrointestinal in Chronic Gastritis

Figure 8. Global Gastrointestinal Market: Chronic Gastritis (2017-2022) & ($ Millions)

Figure 9. Gastrointestinal in Functional Dyspepsia

Figure 10. Global Gastrointestinal Market: Functional Dyspepsia (2017-2022) & ($ Millions)

Figure 11. Gastrointestinal in Peptic Ulcer

Figure 12. Global Gastrointestinal Market: Peptic Ulcer (2017-2022) & ($ Millions)

Figure 13. Gastrointestinal in Acute Gastroenteritis

Figure 14. Global Gastrointestinal Market: Acute Gastroenteritis (2017-2022) & ($ Millions)

Figure 15. Gastrointestinal in Others

Figure 16. Global Gastrointestinal Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Gastrointestinal Market Size Market Share by Application in 2021

Figure 18. Global Gastrointestinal Revenue Market Share by Player in 2021

Figure 19. Global Gastrointestinal Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Gastrointestinal Market Size 2017-2022 ($ Millions)

Figure 21. APAC Gastrointestinal Market Size 2017-2022 ($ Millions)

Figure 22. Europe Gastrointestinal Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Gastrointestinal Market Size 2017-2022 ($ Millions)

Figure 24. Americas Gastrointestinal Value Market Share by Country in 2021

Figure 25. Americas Gastrointestinal Consumption Market Share by Type in 2021

Figure 26. Americas Gastrointestinal Market Size Market Share by Application in 2021

Figure 27. United States Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Gastrointestinal Market Size Market Share by Region in 2021

Figure 32. APAC Gastrointestinal Market Size Market Share by Application in 2021

Figure 33. China Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Gastrointestinal Market Size Market Share by Country in 2021

Figure 40. Europe Gastrointestinal Market Size Market Share by Type in 2021

Figure 41. Europe Gastrointestinal Market Size Market Share by Application in 2021

Figure 42. Germany Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Gastrointestinal Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Gastrointestinal Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Gastrointestinal Market Size Market Share by Application in 2021

Figure 50. Egypt Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Gastrointestinal Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 56. APAC Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 57. Europe Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 59. United States Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 60. Canada Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 63. China Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 64. Japan Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 65. Korea Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 67. India Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 68. Australia Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 69. Germany Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 70. France Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 71. UK Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 72. Italy Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 73. Russia Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 74. Spain Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 77. Israel Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Gastrointestinal Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Gastrointestinal Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390